Epitope-positive truncating MLH1 mutation and loss of PMS2: implications for IHC-directed genetic testing for Lynch syndrome.

Abstract:

:We assessed mismatch repair by immunohistochemistry (IHC) and microsatellite instability (MSI) analysis in an early onset endometrial cancer and a sister's colon cancer. We demonstrated high-level MSI and normal expression for MLH1, MSH2 and MSH6. PMS2 failed to stain in both tumors, strongly implicating a PMS2 defect. This family did not meet clinical criteria for Lynch syndrome. However, early onset endometrial cancers in the proband and her sister, a metachronous colorectal cancer in the sister as well as MSI in endometrial and colonic tumors suggested a heritable mismatch repair defect. PCR-based direct exonic sequencing and multiplex ligation-dependent probe amplification (MLPA) were undertaken to search for PMS2 mutations in the germline DNA from the proband and her sister. No mutation was identified in the PMS2 gene. However, PMS2 exons 3, 4, 13, 14, 15 were not evaluated by MLPA and as such, rearrangements involving those exons cannot be excluded. Clinical testing for MLH1 and MSH2 mutation revealed a germline deletion of MLH1 exons 14 and 15. This MLH1 germline deletion leads to an immunodetectable stable C-terminal truncated MLH1 protein which based on the IHC staining must abrogate PMS2 stabilization. To the best of our knowledge, loss of PMS2 in MLH1 truncating mutation carriers that express MLH1 in their tumors has not been previously reported. This family points to a potential limitation of IHC-directed gene testing for suspected Lynch syndrome and the need to consider comprehensive MLH1 testing for individuals whose tumors lack PMS2 but for whom PMS2 mutations are not identified.

journal_name

Fam Cancer

journal_title

Familial cancer

authors

Zighelboim I,Powell MA,Babb SA,Whelan AJ,Schmidt AP,Clendenning M,Senter L,Thibodeau SN,de la Chapelle A,Goodfellow PJ

doi

10.1007/s10689-009-9276-2

subject

Has Abstract

pub_date

2009-01-01 00:00:00

pages

501-4

issue

4

eissn

1389-9600

issn

1573-7292

journal_volume

8

pub_type

杂志文章
  • Uptake of genetic counseling, genetic testing and surveillance in hereditary malignant melanoma (CDKN2A) in Norway.

    abstract::Germline mutations in the CDKN2A gene are associated with an increased risk of malignant melanoma and pancreatic cancer. In order to find out if the behavior pattern in families with a CDKN2A mutation is similar to what we previously have described in families with a BRCA1 mutation, we have studied the uptake of genet...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-016-9939-8

    authors: Levin T,Mæhle L

    更新日期:2017-04-01 00:00:00

  • Disclosing cancer genetic information within families: perspectives of counselees and their at-risk relatives.

    abstract:PURPOSE:The aim of the present descriptive study was to investigate the experience of sharing genetic information among cancer genetic counselees and their at-risk relatives. METHODS:In total, 147 cancer genetic counselees and 81 of their at-risk relatives answered to a study specific questionnaire and/or were intervi...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-010-9364-3

    authors: Hayat Roshanai A,Lampic C,Rosenquist R,Nordin K

    更新日期:2010-12-01 00:00:00

  • Analysis of BRCA1/BRCA2 genes' contribution to breast cancer susceptibility in high risk Jewish Ashkenazi women.

    abstract:BACKGROUND:Three mutations in BRCA1 (185delAG 5382InsC) and BRCA2 (6174delT) can be detected in a substantial proportion of Jewish Ashkenazi breast/ovarian cancer families. Family-specific pathogenic mutations in both genes can be detected in up to 5% of high risk Ashkenazim. The contribution of major gene rearrangemen...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-008-9216-6

    authors: Distelman-Menachem T,Shapira T,Laitman Y,Kaufman B,Barak F,Tavtigian S,Friedman E

    更新日期:2009-01-01 00:00:00

  • Waiting and "weighted down": the challenge of anticipatory loss for individuals and families with Li-Fraumeni Syndrome.

    abstract::Li-Fraumeni Syndrome (LFS) is characterized by risk of multiple primary malignancies in diverse sites, pediatric onset, near complete penetrance by age 70 years, limited options for prevention, and substantial uncertainty regarding disease manifestation and prognosis. Forty-five families, including 117 individuals age...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-020-00173-6

    authors: Werner-Lin A,Young JL,Wilsnack C,Merrill SL,Groner V,Greene MH,Khincha PP

    更新日期:2020-07-01 00:00:00

  • Response to neo-adjuvant chemotherapy in BRCA1 and BRCA2 related stage III breast cancer.

    abstract::Pathological features and consequently, tumor response differ between BRCA1/2 carriers and sporadic breast cancer (BC) cases. It is expected that BRCA1/2 associated tumors will be more vulnerable to DNA damaging agents and irradiation due to their function in DNA repair. In addition, very high pathological complete re...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-008-9223-7

    authors: Hubert A,Mali B,Hamburger T,Rottenberg Y,Uziely B,Peretz T,Kadouri L

    更新日期:2009-01-01 00:00:00

  • Two TP53 germline mutations in a classical Li-Fraumeni syndrome family.

    abstract::Li-Fraumeni syndrome (LFS) is an autosomal dominantly inherited cancer predisposition syndrome characterized by a combination of tumors including sarcoma, breast cancer, brain tumors, adrenocortical carcinoma and leukemia. Germline mutations in the tumor suppressor gene TP53 are associated with LFS. We present a famil...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-006-9115-7

    authors: van Hest LP,Ruijs MW,Wagner A,van der Meer CA,Verhoef S,van't Veer LJ,Meijers-Heijboer H

    更新日期:2007-01-01 00:00:00

  • Prediction models in Lynch syndrome.

    abstract::Prediction models for the identification of Lynch syndrome have been developed to quantify an individual's risk of carrying a mismatch repair gene mutation and help clinicians decide for whom further risk assessment and genetic testing is necessary. There are diverse clinical settings in which a healthcare provider ha...

    journal_title:Familial cancer

    pub_type: 杂志文章,评审

    doi:10.1007/s10689-013-9632-0

    authors: Kastrinos F,Balmaña J,Syngal S

    更新日期:2013-06-01 00:00:00

  • Can a phenotype for recessive inheritance in breast cancer be defined?

    abstract::While a dominant inheritance of breast cancer (vertical inheritance) is well known, less is known about a possible recessive inheritance (horizontal inheritance). In a clinical series of 1676 breast cancer patient's family history was scored as vertical (grandmother-aunt-mother-sister-daughter) or horizontal (sister-s...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-010-9355-4

    authors: Ellberg C,Jönsson G,Olsson H

    更新日期:2010-12-01 00:00:00

  • Screening behavior in women at increased familial risk for breast cancer.

    abstract::This multicenter study examined the adherence of high-risk women to screening recommendations for breast and ovarian cancer following consultation at a familial cancer clinic (FCC). Self-report questionnaires assessing recall of screening advice, tests undertaken, risk perception, anxiety (Impact of Events Scale) and ...

    journal_title:Familial cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1007/s10689-006-0006-8

    authors: Antill YC,Reynolds J,Young MA,Kirk JA,Tucker KM,Bogtstra TL,Wong SS,Dudding TE,Di Iulio JL,Phillips KA

    更新日期:2006-01-01 00:00:00

  • Multi-gene panel testing confirms phenotypic variability in MUTYH-Associated Polyposis.

    abstract::Biallelic pathogenic variants (PVs) in MUTYH cause MUTYH-Associated Polyposis (MAP), which displays phenotypic overlap with other hereditary colorectal cancer (CRC) syndromes including Familial Adenomatous Polyposis (FAP) and Lynch syndrome. We report the phenotypic spectrum of MAP in the context of multi-gene heredit...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-018-00116-2

    authors: Sutcliffe EG,Bartenbaker Thompson A,Stettner AR,Marshall ML,Roberts ME,Susswein LR,Wang Y,Klein RT,Hruska KS,Solomon BD

    更新日期:2019-04-01 00:00:00

  • Evolution of the nomenclature for the hereditary colorectal cancer syndromes.

    abstract::The hereditary forms of colorectal cancer have been given many names historically as the manifestations have been gradually understood. Lynch syndrome has had several names, most prominently 'Hereditary Nonpolyposis Colorectal Cancer' or HNPCC. Clarification of the genetic basis and full phenotypic expression of this ...

    journal_title:Familial cancer

    pub_type: 杂志文章,评审

    doi:10.1007/s10689-004-4489-x

    authors: Boland CR

    更新日期:2005-01-01 00:00:00

  • Ovarian small cell carcinoma in one of a pair of monozygous twins.

    abstract::One of a pair of monozygous twins was diagnosed and died of small cell carcinoma of the ovary of hypercalcemic type (SCCOHT) at the age of 30 years. Her sister remained unaffected and was very concerned about her risk for developing SCCOHT. By performing comprehensive molecular analysis using whole exome sequencing (W...

    journal_title:Familial cancer

    pub_type: 信件

    doi:10.1007/s10689-018-0108-0

    authors: Fahiminiya S,Sabbaghian N,Albrecht S,Nadaf J,Callegaro-Filho D,Foulkes WD

    更新日期:2019-04-01 00:00:00

  • Communicating genetic test results within the family: Is it lost in translation? A survey of relatives in the randomized six-step study.

    abstract::Genetic testing for cancer susceptibility genes is increasingly being integrated into medical care. Test results help inform risks of the individual being tested as well as family members who could benefit from knowing the results. The responsibility for informing relatives of genetic test results falls on the proband...

    journal_title:Familial cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1007/s10689-016-9889-1

    authors: Daly MB,Montgomery S,Bingler R,Ruth K

    更新日期:2016-10-01 00:00:00

  • Two BRCA1/2 founder mutations in Jews of Sephardic origin.

    abstract::Founder mutations in BRCA1/2 genes have been detected in several Jewish communities in Israel, including in Ashkenazi Jews and Jews who immigrated to Israel from Iraq, Yemen, Iran and Afghanistan. We analyzed DNA samples of patients of Sephardic origin (descendents of Jews from the Iberian Peninsula) with breast cance...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-010-9395-9

    authors: Sagi M,Eilat A,Ben Avi L,Goldberg Y,Bercovich D,Hamburger T,Peretz T,Lerer I

    更新日期:2011-03-01 00:00:00

  • Lack of germ-line mutations at the specific BRCA1-IRIS coding sequence in 114 Spanish high-risk breast/ovarian families.

    abstract::A new BRCA1 locus product called BRCA1-IRIS has been identified recently. High-risk breast/ovarian families have not been screened for germ-line mutations at the specific BRCA1-IRIS coding sequence, as it was considered merely as part of BRCA1 intron 11. Here we report the first comprehensive screening of germ-line mu...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-005-1236-x

    authors: de la Hoya M,Fernández JM,Sánchez de Abajo A,Tosar A,Díaz-Rubio E,Caldés T

    更新日期:2005-01-01 00:00:00

  • Low contribution of BRCA1/2 genomic rearrangement to high-risk breast cancer in the Korean population.

    abstract::Genomic rearrangement occasionally affects the BRCA1/2 genes in Caucasian breast cancer patients. However, the incidence of BRCA1/2 genomic rearrangement in Asians, including the Korean population, has not been well established. Here, we investigated the contribution of BRCA1/2 genomic rearrangement to high-risk breas...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-009-9279-z

    authors: Seong MW,Cho SI,Noh DY,Han W,Kim SW,Park CM,Park HW,Kim SY,Kim JY,Park SS

    更新日期:2009-01-01 00:00:00

  • Whole exome sequencing identifies mutation of EDNRA involved in ACTH-independent macronodular adrenal hyperplasia.

    abstract::ACTH independent macronodular adrenal hyperplasia (AIMAH) is a rare disorder characterized by bilateral macronodular hyperplasia of the adrenal glands and increased cortisol production with subclinical or overt Cushing's syndrome. Although the family clustering of AIMAH is infrequent, we have tried our best to find su...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-013-9642-y

    authors: Zhu J,Cui L,Wang W,Hang XY,Xu AX,Yang SX,Dou JT,Mu YM,Zhang X,Gao JP

    更新日期:2013-12-01 00:00:00

  • Uroepithelial and kidney carcinoma in Lynch syndrome.

    abstract::Increased risk for urological tumors has been observed in mutation carriers with Lynch syndrome (LS). In this study, we evaluated the clinical features of uroepithelial (bladder and ureter) and kidney cancers in 974 Finnish mutation carriers. Altogether 30 patients had a total of 34 urological tumors: 12 ureter, 12 bl...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-012-9526-6

    authors: Aarnio M,Säily M,Juhola M,Gylling A,Peltomäki P,Järvinen HJ,Mecklin JP

    更新日期:2012-09-01 00:00:00

  • NTHL1-associate polyposis: first Australian case report.

    abstract::While familial adenomatous polyposis accounts for approximately 1% of all colorectal cancer, the genetic cause underlying the development of multiple colonic adenomas remains unsolved in many patients. Adenomatous polyposis syndromes can be divided into: familial adenomatous polyposis, MUTYH-associated polyposis, poly...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-018-0107-1

    authors: Groves A,Gleeson M,Spigelman AD

    更新日期:2019-04-01 00:00:00

  • Hereditary medullary thyroid carcinoma syndromes: experience from western India.

    abstract::The data from the Indian subcontinent on Medullary thyroid carcinoma (MTC) and associated endocrinopathies in hereditary MTC (HMTC) syndromes are limited. Hence, we analyzed clinical and biochemical characteristics, management, and outcomes of HMTC and other associated endocrinopathies [Pheochromocytoma (PCC) and Prim...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-020-00219-9

    authors: Diwaker C,Sarathi V,Jaiswal SK,Shah R,Deshmukh A,Thomas AE,Prakash G,Malhotra G,Patil V,Lila A,Shah N,Bandgar T

    更新日期:2021-01-04 00:00:00

  • The InSiGHT database: utilizing 100 years of insights into Lynch syndrome.

    abstract::This article provides a historical overview of the online database ( www.insight-group.org/mutations ) maintained by the International Society for Gastrointestinal Hereditary Tumours. The focus is on the mismatch repair genes which are mutated in Lynch Syndrome. APC, MUTYH and other genes are also an important part of...

    journal_title:Familial cancer

    pub_type: 历史文章,杂志文章

    doi:10.1007/s10689-013-9616-0

    authors: Plazzer JP,Sijmons RH,Woods MO,Peltomäki P,Thompson B,Den Dunnen JT,Macrae F

    更新日期:2013-06-01 00:00:00

  • The natural history of a combined defect in MSH6 and MUTYH in a HNPCC family.

    abstract::In the inherited syndromes, MUTYH-associated polyposis (MAP) and hereditary nonpolyposis colorectal cancer (HNPCC), somatic mutations occur due to loss of the caretaker function that base-repair (BER) and mismatch repair (MMR) genes have, respectively. Recently, we identified a large branch from a MSH6 HNPCC family in...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-006-9103-y

    authors: van Puijenbroek M,Nielsen M,Reinards TH,Weiss MM,Wagner A,Hendriks YM,Vasen HF,Tops CM,Wijnen J,van Wezel T,Hes FJ,Morreau H

    更新日期:2007-01-01 00:00:00

  • Sarcomas associated with hereditary nonpolyposis colorectal cancer: broad anatomical and morphological spectrum.

    abstract::Hereditary nonpolyposis colorectal cancer (HNPCC) is primarily linked to colorectal and endometrial cancer, but is associated with a broad tumor spectrum. Though not formally part of the syndrome, occasional sarcomas have been reported in individuals with HNPCC. We used the national Danish HNPCC-register to identify H...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-008-9230-8

    authors: Nilbert M,Therkildsen C,Nissen A,Akerman M,Bernstein I

    更新日期:2009-01-01 00:00:00

  • Cancer in Jews: introduction and overview.

    abstract::This article is based upon a literature overview of cancer in Jews. It involves a comparison of variation in incidence and prevalence rates between Jews and non-Jews. However, the reader must exercise a certain amount of skepticism when considering secular changes in cancer incidence and prevalence and the public heal...

    journal_title:Familial cancer

    pub_type: 杂志文章,评审

    doi:10.1007/s10689-004-9538-y

    authors: Lynch HT,Rubinstein WS,Locker GY

    更新日期:2004-01-01 00:00:00

  • Hereditary diffuse gastric cancer: cancer risk and the personal cost of preventive surgery.

    abstract::Germline CDH1 mutation carriers are at risk for early-onset diffuse gastric cancer (DGC) and female carriers have an additional risk of lobular breast cancer. The reported literature GC risk of 70% has led to the recommendation for germline mutation carriers to undergo prophylactic total gastrectomy (PTG). The objecti...

    journal_title:Familial cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1007/s10689-019-00133-9

    authors: Kaurah P,Talhouk A,MacMillan A,Lewis I,Chelcun-Schreiber K,Yoon SS,Huntsman D

    更新日期:2019-10-01 00:00:00

  • Frameshift mutation in the PTCH2 gene can cause nevoid basal cell carcinoma syndrome.

    abstract::Nevoid basal cell carcinoma syndrome (NBCCS) is an autosomal dominant disorder characterized by developmental defects and tumorigenesis. The gene responsible for NBCCS is PTCH1, encoding a receptor for the secreted protein, sonic hedgehog. Recently, a Chinese family with NBCCS carrying a missense mutation in PTCH2, a ...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-013-9623-1

    authors: Fujii K,Ohashi H,Suzuki M,Hatsuse H,Shiohama T,Uchikawa H,Miyashita T

    更新日期:2013-12-01 00:00:00

  • Chemoprevention with special reference to inherited colorectal cancer.

    abstract::Familial Adenomatous Polyposis (FAP) is a model for the adenoma-carcinoma sequence in several respects. One important area in which FAP serves as a model is chemoprevention. Early prevention trials mainly utilized micronutrients and were largely unsuccessful in preventing or causing regression of adenomas. A new era w...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-007-9158-4

    authors: Lynch PM

    更新日期:2008-01-01 00:00:00

  • Association between miR-146a rs2910164 polymorphism and specific cancer susceptibility: an updated meta-analysis.

    abstract::The rapidly increasing of cancer risk nationwide and worldwide has threatened human health and caused the changes of disease and death spectrum. MicroRNA (MiRNA) as cancer biomarker on susceptibility has enjoyed a high level of concern. This article will discuss the association between miR-146 rs2910164 polymorphism a...

    journal_title:Familial cancer

    pub_type: 杂志文章,meta分析,评审

    doi:10.1007/s10689-017-0056-0

    authors: Hao X,Xia L,Qu R,Yang X,Jiang M,Zhou B

    更新日期:2018-07-01 00:00:00

  • The 1100delAT BRCA1 and the 8765delAG BRCA2 mutations: occurrence in high-risk non-Ashkenazi Jews and haplotype comparison of Jewish and non-Jewish carriers.

    abstract::Few mutations have been described in BRCA1 and BRCA2 in high-risk non-Ashkenazi Jews. In a Libyan family the 1100delAT BRCA1 mutation was detected and the 8765delAG BRCA2 mutation was previously described in two Jewish-Yemenite-families. In this study, the rate of these mutations in high-risk Jews of North African and...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1023/B:FAME.0000026837.32470.b4

    authors: Gal I,Gershoni Baruch R,Haber D,Dagan E,Eisenberg-Barzilai S,Zidan J,Friedman E

    更新日期:2004-01-01 00:00:00

  • Improving primary care identification of familial breast cancer risk using proactive invitation and decision support.

    abstract::Family history of breast cancer is a key risk factor, accounting for up to 10% of cancers. We evaluated the proactive assessment of familial breast cancer (FBC) risk in primary care. Eligible women (30 to 60 years) were recruited from eight English general practices. Practices were trained on FBC risk assessment. In f...

    journal_title:Familial cancer

    pub_type: 杂志文章

    doi:10.1007/s10689-020-00188-z

    authors: Qureshi N,Dutton B,Weng S,Sheehan C,Chorley W,Robertson JFR,Kendrick D,Kai J

    更新日期:2020-06-11 00:00:00